Myasthenia Gravis Trial, Recruiting (NCT06881173)

Myasthenia Gravis Trial, Recruiting NCT06881173 Sponsor: Cheng, yu-ting Condition: Myasthenia Gravis

Printed from Voxsanity (voxsanity.com.au) — NCT06881173 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Myasthenia Gravis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been diagnosed with ocular myasthenia (a condition affecting the muscles around the eyes) by a doctor
You are only taking one specific Western medicine tablet called Mestinon (pyridostigmine bromide) by mouth for this condition
You are over 20 years old
You can speak and understand Mandarin or Taiwanese
You are mentally alert and have not been diagnosed with a mental illness
You and your family are willing to receive a treatment approach that combines both traditional Chinese medicine and Western medicine

Who may not be able to join:

You have been diagnosed with liver failure or kidney failure
You have had allergic reactions to traditional Chinese medicine, such as skin itching or redness
You have been diagnosed with a malignant tumor (cancer)
You are currently receiving radiotherapy or chemotherapy
You are pregnant
You have a cardiac rhythm device fitted (such as a pacemaker) (confirm with trial site)

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Ju-Han Liu, project leader

Phone: +8860988773890

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06881173

Sponsor: Cheng, yu-ting

Phase: Not Applicable

Status: Recruiting

Condition: Myasthenia Gravis

Trial contact: +8860988773890

More information: https://clinicaltrials.gov/study/NCT06881173

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been diagnosed with ocular myasthenia (a condition affecting the muscles around the eyes) by a doctor
You are only taking one specific Western medicine tablet called Mestinon (pyridostigmine bromide) by mouth for this condition
You are over 20 years old
You can speak and understand Mandarin or Taiwanese
You are mentally alert and have not been diagnosed with a mental illness
You and your family are willing to receive a treatment approach that combines both traditional Chinese medicine and Western medicine

Who may not be able to join:

You have been diagnosed with liver failure or kidney failure
You have had allergic reactions to traditional Chinese medicine, such as skin itching or redness
You have been diagnosed with a malignant tumor (cancer)
You are currently receiving radiotherapy or chemotherapy
You are pregnant
You have a cardiac rhythm device fitted (such as a pacemaker) (confirm with trial site)

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Cheng, yu-ting

Registry

ClinicalTrials.gov

Start date

14 June 2022

Est. completion

13 June 2025

Where this trial is recruiting

🇹🇼 Taiwan

Primary endpoints

meridian energy; autonomic nervous system function

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov